文献速递呼吸衰竭与机械通气

高流量鼻导管氧疗与无创通气治疗成人急性呼吸衰竭:随机对照试验的系统评价

High flow nasal cannula oxygen versus noninvasive ventilation in adult acute respiratory failure: a systematic review of randomized-controlled trials.
PubMed 文献 · Eur J Emerg Med · 2019-01-01
一句话结论系统评价显示,在成人低氧性急性呼吸衰竭(PaO2/FiO2≤300 mmHg)患者中,HFNC与NIV在插管/再插管率上结果矛盾,部分次要结局(ICU死亡率、耐受性)倾向于HFNC。

该系统评价纳入5项随机对照试验,比较成人急性呼吸衰竭(PaO2/FiO2≤300 mmHg)患者使用高流量鼻导管氧疗(HFNC)与无创通气(NIV)。3项试验比较HFNC与NIV,1项比较HFNC、NIV与氧疗,1项比较HFNC+NIV与NIV。由于异质性无法合并结果。在3项以插管/再插管为主要结局的试验中,HFNC与NIV组间插管/再插管率的比值比范围为0.80(95%CI 0.54-1.19)至1.65(95%CI 0.96-2.84)。次要结局包括ICU死亡率和患者耐受性差异,倾向于HFNC。结果相互矛盾,但指出了未来研究方向,包括高碳酸血症性急性呼吸衰竭、更严重低氧血症(PaO2/FiO2≤200 mmHg)、优效性设计、氧疗组和以患者为中心的结局。

要点

  • 在成人低氧性急性呼吸衰竭(PaO2/FiO2≤300 mmHg)患者中,3项以插管/再插管为主要结局的试验显示,HFNC与NIV组间插管/再插管率的比值比范围为0.80(95%CI 0.54-1.19)至1.65(95%CI 0.96-2.84)。
  • 在2项以支气管镜或插管期间最低外周毛细血管血氧饱和度为主要结局的试验中,仅1项报告插管期间NIV+HFNC与NIV组间最低外周毛细血管血氧饱和度差异有统计学意义[100%(四分位距95-100)vs 96%(四分位距92-99);P=0.029]。
  • 次要结局包括ICU死亡率和患者耐受性差异,倾向于HFNC。
  • 由于异质性无法合并结果,结果相互矛盾。
  • 未来研究方向包括高碳酸血症性急性呼吸衰竭、更严重低氧血症(PaO2/FiO2≤200 mmHg)、优效性设计、氧疗组和以患者为中心的结局。

适用人群与场景

  • 成人急性呼吸衰竭患者,低氧血症(PaO2/FiO2≤300 mmHg),包括心脏胸外科术后、内科/外科混合患者和肺炎患者。
  • 两项试验在拔管后进行,两项在插管前进行,一项在插管期间进行。

诊断标准与关键阈值

  • 低氧性急性呼吸衰竭:PaO2/FiO2≤300 mmHg。

研究设计与关键结果

  • 系统评价纳入5项随机对照试验;3项比较HFNC与NIV,1项比较HFNC、NIV与氧疗,1项比较HFNC+NIV与NIV。
  • 3项试验以插管/再插管率为主要结局,HFNC与NIV组间比值比范围为0.80(95%CI 0.54-1.19)至1.65(95%CI 0.96-2.84)。
  • 2项试验以支气管镜或插管期间最低外周毛细血管血氧饱和度为主要结局;仅1项报告插管期间NIV+HFNC与NIV组间差异有统计学意义[100%(四分位距95-100)vs 96%(四分位距92-99);P=0.029]。
  • 次要结局包括ICU死亡率和患者耐受性差异,倾向于HFNC。

证据类型、等级与局限

  • 证据类型:随机对照试验的系统评价。
  • 3项试验为优效性设计,2项为非劣效性设计。
  • 由于异质性无法合并结果。
  • 局限:结果相互矛盾。

对床旁实践的改变

  • 在成人低氧性急性呼吸衰竭(PaO2/FiO2≤300 mmHg)患者中,HFNC与NIV在插管/再插管率上的比较结果相互矛盾,现有证据无法确定孰优。
  • 次要结局(ICU死亡率和患者耐受性)差异倾向于HFNC。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

We reviewed the use of noninvasive ventilation (NIV) versus high flow nasal cannula (HFNC) oxygen in adult acute respiratory failure (ARF). We searched major databases and included randomized trials comparing at least NIV with HFNC or NIV+HFNC with NIV in ARF. Primary outcomes included intubation/re-intubation rates. Secondary outcomes were ICU mortality and morbidities. Five trials were included; three compared HFNC with NIV, one compared HFNC, NIV and oxygen whereas one compared HFNC+NIV with NIV. Patients had hypoxaemic ARF (PaO2/FiO2≤300 mmHg). Heterogeneity prevented result pooling. Three and two studies had superiority and noninferiority design, respectively. Patients were postcardiothoracic surgery, mixed medical/surgical patients and those with pneumonia. Two trials were conducted after extubation, two before intubation and one during intubation. Three trials reported intubation/re-intubation rates as the primary outcomes. The other two trials reported the lowest peripheral capillary oxygen saturation readings during bronchoscopy or intubation. In the former three trials, the odds ratio for intubation/re-intubation rates between HFNC versus the NIV group ranged from 0.80 (95% confidence interval: 0.54-1.19) to 1.65 (95% confidence interval: 0.96-2.84). In the latter two trials, only one reported a difference in the lowest peripheral capillary oxygen saturation between NIV+HFNC versus the NIV group during intubation [100% (interquartile range: 95-100) vs. 96% (interquartile range: 92-99); P=0.029]. The secondary outcomes included differences in ICU mortality and patient tolerability, favouring HFNC. Results were conflicting, but highlighted future research directions. These include patients with hypercapneic ARF, more severe hypoxaemia (PaO2/FiO2≤200 mmHg), a superiority design, an oxygen arm and patient-centred outcomes.

来源:Eur J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Beng Leong L, Wei Ming N, Wei Feng L, et al. High flow nasal cannula oxygen versus noninvasive ventilation in adult acute respiratory failure: a systematic review of randomized-controlled trials. Eur J Emerg Med. 2019. PMID: 29923842. doi:10.1097/MEJ.0000000000000557

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。